NQH WART REMOVER - Guangzhou Huixue Biotechnology Co., Ltd.
- Manufacturer
- Guangzhou Huixue Biotechnology Co., Ltd.
- Effective date
- 2026-10-17
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- daily-update
- Hydrated at
- 2026-10-20 03:02:13
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Salicylic Acid 45%
INACTIVE INGREDIENT SECTION
Water, Borneol, Glycerin, Polyethylene Glycol, Bisabolol, Allantoin, Lonicera Japonica (Honeysuckle) Flower Extract, Sophora Angustifolia Root Extract, Hyaluronic Acid, Aloe Vera Extract,Cnidium Monnieri Extract, Gentiana Scabra Root Extract, Portulaca Oleracea Extract, Zingiber Officinale (Ginger) Root Extract
OTC - PURPOSE SECTION
For the removal of warts
INDICATIONS & USAGE SECTION
For the removal of warts, including plantar warts, flat warts, common warts, corns, and calluses.1.Clean the affected area. You can soak the affected area in warm water for 5 minutes (optional). 2. Take an appropriate amount of the solution and apply it to the affected area, making sure it covers complete ly. Wait for it to dry. 3. Repeat this process 2-3 times daily until the skin looks smooth.
WARNINGS SECTION
For external use only. Flammable Keep away from fire and flame. Keep out of reach of children. Avoid contact with eyes, in case of contact, flush eyes with plenty of cool water. Do not swallow, if swallowed, seek medical attention or contact a Poison Control Center (1-800-222-1222) immediately.Children should use this product under adult supervision. Avoid prolonged exposure to air during use as the substance may dissolve and crystallize easily.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Store at room temperature. Avoid excessive heat above 37°C (99°F).
OTC - WHEN USING SECTION
1.Clean the affected area. You can soak the affected area in warm water for 5 minutes (optional). 2. Take an appropriate amount of the solution and apply it to the affected area, making sure it covers completely. Wait for it to dry. 3. Repeat this process 2-3 times daily until the skin looks smooth. 4. More severe may require more time.Patience and perseverance are required during its use. The longest continuous use period is no more than 12 weeks.
OTC - DO NOT USE SECTION
If you are allergic to any ingredient in this product. •On moles, birthmarks, warts with hair growing from them, genital warts or warts on the face or mucous membranes. If you have diabetes or poor blood circulation. If you are pregnant or breastfeeding unless directed by a healthcare practitioner.
OTC - STOP USE SECTION
You become pregnant or are trying to become pregnant while using this product. Irritation or redness occurs, worsens, or does not improve with continued use.
DOSAGE & ADMINISTRATION SECTION
1.Clean the affected area. You can soak the affected area in warm water for 5 minutes (optional). 2. Take an appropriate amount of the solution and apply it to the affected area, making sure it covers completely. Wait for it to dry. 3. Repeat this process 2-3 times daily until the skin looks smooth
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Products#
Every source-derived product name is available through these pages.
- NQH WART REMOVER
- Salicylic Acid 45%
- SALICYLIC ACID
- WATER
- BORNEOL
- GLYCERIN
- BISABOLOL
- ALLANTOIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 87204-223 | 87204-223-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| WATER | 059QF0KO0R | IACT |
| BORNEOL | M89NIB437X | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| BISABOLOL | 24WE03BX2T | IACT |
| ALLANTOIN | 344S277G0Z | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
